Webb19 nov. 2024 · Swiss pharmaceutical company Novartis has invested in a US-based materials science company SiO2 Medical Products to use its technology in a variety of products. The investment in SiO2 Medical Products is co-led by a US-based healthcare investment firm MPM Capital. SiO2 said that its patented technology is expected to … Webb1 sep. 2024 · Prothena Appoints Biotechnology Industry Leader Helen S. Kim to its Board of Directors Helen S. Kim DUBLIN, Ireland, Sept. 01, 2024 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, …
Protego Biopharma LinkedIn
WebbProtego Biopharma focuses on the discovery and development of small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. Webb22 juni 2024 · Plakous Therapeutics released a press release to announce that Protego-PD™, their therapy for infants with necrotizing enterocolitis (NEC), received both the … scaramouche shinji
PROTEGO - Image Diagnostics Inc
WebbProtego Biopharma 1,125 followers on LinkedIn. The small molecule pharmacological chaperone company Protego Biopharma focuses on the discovery and development of small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. We are building upon our expertise in the proven pharmacological … WebbAbout Protego Biopharma. Protego Biopharma provides therapeutics and diagnostics services. The company's services utilize clear human genetic links to develop Immuno … Webb17 nov. 2024 · Protego is an early-stage biomedical R&D company targeting protein misfolding diseases using a unique small-molecule Pharmacological Chaperone … scaramouche sims 4